Photo edit of the transgender flag. Credit: Alexander J. Williams III/Pop Acta.
Photo edit of the transgender flag. Credit: Alexander J. Williams III/Pop Acta.

A multinational consortium of healthcare professionals has voiced deep concerns over the current approach to transgender healthcare in the United States. Their concerns, aired in the Wall Street Journal, draw attention to the lack of robust scientific evidence supporting the administration of hormonal treatments for transgender minors, citing the heightened risk of infertility, life-long reliance on medication, and potential for remorse.

A diverse collective of healthcare professionals, hailing from the United Kingdom, Sweden, Finland, Norway, France, Switzerland, and the United States, have voiced their concerns over the excessively politicized state of transgender healthcare in the U.S. Their stance champions a return to strategies that are anchored in science and supported by tangible evidence. The group urges medical societies to prioritize the adherence to meticulously verified, evidence-based treatment plans over the tendency to magnify perceived benefits and understate potential risks.

A poignant message shared in the Wall Street Journal by this group of 21 professionals conveys their collective dismay, stating:

“The politicization of transgender healthcare in the U.S. is unfortunate.” The communication goes on to suggest an antidote to the current landscape, advocating that, “The way to combat it is for medical societies to align their recommendations with the best available evidence—rather than exaggerating the benefits and minimizing the risks.”

Systematic reviews, including those published in the Journal of the Endocrine Society, highlight the dearth of high-certainty evidence corroborating the mental-health benefits of hormonal treatments for transgender minors. This is contrasted by the significant risks posed, leading to a rising number of European countries and global professional organizations recommending psychotherapy as the first-line treatment for gender-dysphoric youth.

The scholars also question the widely disseminated notion that gender transition alleviates suicide rates, stressing that comprehensive studies have yet to find definitive evidence in support of this claim. The professionals have also raised awareness of the damage inflicted on many American youths by the politicized endorsement of drugs, hormones, and surgeries for sex change in minors.

Highlighting the European approach of prioritizing psychotherapy and reserving hormonal interventions for extreme cases, the consortium argues for a reconsideration of the current U.S. strategy. Their call for a more circumspect, evidence-based approach to transgender healthcare is a salient reminder of the need for less politics and more science in the medical discourse surrounding transgender health.


  1. The Bible says God made male and female, and not a male who thinks he is a fetrafmale or female think she is a male, who ever you are you need to read the bible,Lev.

  2. See the suicide rates alone
    etc among kids who had treatments & cant go back etc

Leave a Reply

Your email address will not be published. Required fields are marked *